SC
ABMD

Steph & Co’s Abiomed Inc ABMD Stock Holding History

Steph & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45
Closed -$11K – 252
2022
Q3 		$11K Hold
45
– – 0.01% 203
2022
Q2 		$11K Hold
45
– – 0.01% 204
2022
Q1 		$15K Hold
45
– – 0.01% 257
2021
Q4 		$16K Hold
45
– – 0.01% 271
2021
Q3 		$15K Hold
45
– – 0.01% 239
2021
Q2 		$14K Sell
45
-4
-8% -$1.23K 0.01% 209
2021
Q1 		$16K Sell
49
-6
-11% -$1.92K 0.01% 202
2020
Q4 		$18K Hold
55
– – 0.01% 200
2020
Q3 		$15K Hold
55
– – 0.01% 193
2020
Q2 		$13K Hold
55
– – 0.01% 202
2020
Q1 		$8K Hold
55
– – 0.01% 223
2019
Q4 		$9K Buy
+55
New +$10.2K 0.01% 231

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Steph & Co's ABMD Position: Q4 2022 in Review

Steph & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 45 shares — an estimated $11K sold.

Steph & Co first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $18K in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Steph & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Steph & Co sold 45 Abiomed Inc shares in Q4 2022, an estimated $11K.
  • Steph & Co first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Steph & Co's Abiomed Inc position peaked at $18K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Steph & Co's 13F filing for Q4 2022, filed 26 Jan 2023.